Fidelis Diagnostics Expands Services in Southern California by Adding EMG Testing to Its Portfolio
LOS ANGELES--(BUSINESS WIRE)--Nov 29, 2012--Fidelis Diagnostics, Inc., a rapidly growing healthcare company providing innovative diagnostic services nationally, announced it is expanding its portfolio of diagnostic services in Southern California and adding physicians to its medical team and a new regional manager in San Diego. In addition to offering its current nerve conduction velocity tests (NCV) that are used to detect signs of nerve injury, the company is adding electromyogram testing (EMG) for patients who require a complete NCV/EMG protocol. Three prominent Southern California physicians have joined the Fidelis Medical Team and will be conducting the EMG testing.
Fidelis Diagnostics is also expanding its service capabilities geographically to the rapidly growing San Diego area, and has hired Eric Globerson as the new regional manager to oversee its sales operations. An experienced sales professional, Globerson most recently worked as a Sales Manager promoting Amylin Pharmaceuticals’ diabetes products where he significantly increased the company’s market share. He also worked for Bristol-Myers Squibb Pharmaceuticals where he was awarded District Vision Awards for Leadership three years in a row.
“We are pleased to continue to expand our diagnostic services in Southern California with EMG testing and proud to welcome three experienced and talented women physicians to our medical team, as well as our new regional manager in San Diego,” said Flynn Wilson, CEO of Fidelis Diagnostics, Inc. “Complementing our current NCV testing, EMG and NCV tests combined are the gold standard in electrodiagnostics, especially in worker’s compensation cases because they can more comprehensively and accurately detect work injuries, including carpal tunnel syndrome, cervical and lumbar radiculopathies, generalized peripheral neuropathies, generalized nerve injuries or muscle diseases.” The new Fidelis Medical Team includes: Giang-Tuyet Lam, M.D. completed her Neuromuscular Medicine fellowship at UCLA’s David Geffen School of Medicine and residency in Physical Medicine and Rehabilitation at Loma Linda University. She earned her B.S. degree at University of California, Irvine. Nancy Lin, M.D. is board certified and completed her medical training at Loma Linda University Medical Center in Physical Medicine and Rehabilitation. Dr. Lin is a graduate of New York Medical College and has conducted research at UCLA, Stanford and Loma Linda University. Shalini Mahajan, M.D. is a board certified neurologist with expertise in neuromuscular disorders and electrodiagnostic studies. Dr. Mahajan completed her Neuromuscular Medicine fellowship at UCLA’s David Geffen School of Medicine and Clinical Neuromuscular Diseases fellowship at University of Southern California following earning her medical degree at Maulana Azad Medical College in New Delhi, India. Under the expert leadership of Fidelis Diagnostics’ Medical Director Glen Halvorson, M.S., M.D., Drs. Lam, Lin and Mahajan will be conducting EMG testing at convenient locations in Southern California. Dr. Halvorson is board certified in Physical Medicine and Rehabilitation and in Neuromuscular and Electrodiagnostic Medicine, and a Qualified Medical Examiner for the State of California.
About Fidelis Diagnostics, Inc.
Headquartered in Los Angeles, Fidelis Diagnostics is a rapidly growing healthcare company providing a portfolio of innovative diagnostic services to physicians nationwide. Since its inception in 2004, the company has built an exceptional reputation for its quality diagnostics, high standard of business ethics and outstanding service, improving patient health with convenient testing, while reducing overall healthcare costs. In addition to the newly added EMG testing, Fidelis services include ElectroDiagnostics, Home Sleep Studies, Audiology Testing, and ABI technology, which are being provided to thousands of physicians across the United States. For more information, visit www.fidelisdiagnostics.com.CONTACT: Agnes Huff Communications Agnes Huff, PhD 310-641-2525 firstname.lastname@example.org KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES GENERAL HEALTH SOURCE: Fidelis Diagnostics, Inc. Copyright Business Wire 2012 PUB: 11/29/2012 09:00 AM/DISC: 11/29/2012 09:00 AM http://www.businesswire.com/news/home/20121129005209/